longbridge

Aprea Therapeutics

APRE
----

All Shareholders

Shareholder Type

  • Public and others52.00%
  • Hedge funds18.16%
  • Institutions10.77%
  • VC/PE firms10.10%
  • Individuals & Insiders8.98%

Major Shareholders

Major Shareholders Latest
Shareholder
Soleus Capital LLC
10.10%1.27M--+1.27M
Soleus Capital Management, L.P.
10.10%1.27M--+1.27M
Aigh Capital Management, LLC
8.07%1.02M0.41%+0
Laurence Lytton
3.10%390.81K2.59%-291.03K
Oren GiladCo-Founder, CEO, President & Director
2.93%368.80K0.11%+4.48K
Vestal Point Capital, LP
2.78%350.00K0.14%+0
Sphera Funds Management Ltd
2.14%270.00K0.11%+0
Marc DueyIndependent Director
2.04%256.76K0.09%+1.05K
Nantahala Capital Management, LLC
1.63%205.76K0.08%+0
Renaissance Technologies LLC
0.84%105.80K0.63%+80.70K
Geode Capital Management, LLC
0.59%74.87K0.40%-44.26K
Vanguard Capital Management, LLC
0.49%61.35K<0.01%+3.26K
Citadel Advisors LLC
0.47%58.60K0.47%+58.60K
Bernd SeizingerIndependent Director
0.36%45.78K<0.01%+2.09K
BNP Paribas Financial Markets SNC
0.36%45.21K0.03%+5.39K
Diadema Partners LP
0.36%44.91K--+44.91K
Susquehanna International Group, LLP
0.28%34.94K0.17%+21.92K
John HamillSenior VP, CFO, Principal Accounting Officer & Secretary
0.24%30.07K<0.01%+2.24K
Morgan Stanley
0.21%25.83K0.02%+3.50K
Rifat PamukcuIndependent Director
0.16%19.55K<0.01%+2.09K
© 2026 Longbridge｜Terms of ServicePrivacy Policy